Bikunin Loss in Urine as Useful Marker for Bladder Carcinoma

Journal of Urology

Volumn 183, Issue 1, 2010, Pages 339-344

  Tsui, Ke Hung ^a   Tang, Petrus ^a   Lin, Chiao Yun ^b   Chang, Phei Lang ^a   Chang, Chih Hao ^b   Yung, Benjamin Yat Ming ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

biological; carcinoma; proteomics; tumor markers; urinary bladder; urine

Indexed keywords

PLASMINOGEN ACTIVATOR; ULINASTATIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; TRANSURETHRAL RESECTION; TWO DIMENSIONAL ELECTROPHORESIS; URINALYSIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLOBULINS; CARCINOMA, TRANSITIONAL CELL; HUMANS; MIDDLE AGED; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 71449102739     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.109     Document Type: Article

References (26)

1. Raghaven D., Shipley W.U., Garnick M.B., et al. Biology and management of bladder cancer. New Engl J Med 322 (1990) 1129
2. Newling D.W. Preventing recurrence and progression in superficial bladder cancer. Curr Opin Urol 6 (1996) 272
3. Konety B.R., and Getzenberg R.H. Urine based markers of urological malignancy. J Urol 165 (2001) 600
4. Konety B., and Lotan Y. Urothelial bladder cancer: biomarkers for detection and screening. BJU Int 102 (2008) 1234
5. van Tilborg A.A., Bangma C.H., and Zwarthoff E.C. Bladder cancer biomarkers and their role in surveillance and screening. Int J Urol 16 (2009) 23
6. Ramakumar S., Bhuiyan J., Besse J.A., et al. Comparison of screening methods in the detection of bladder cancer. J Urol 161 (1999) 388
7. Konety B.R. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol Semin Orig Invest 24 (2006) 326
8. Quek M.L., Sanderson K., Daneshmand S., et al. New molecular markers for bladder cancer detection. Curr Opin Urol 14 (2004) 259
9. Sidransky D., Von Eschenbach A., Tsai Y.C., et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252 (1991) 706
10. Kobayashi H., Suzuki M., Hirashima Y., et al. The protease inhibitor birkunin, a novel anti-metastatic agent. Biol Chem 384 (2003) 749
11. Matsuzaki H., Kobayashi H., Yagyu T., et al. Birkunin inhibits lipopolysaccharide-induced tumor necrosis factor alpha induction in macrophages. Clin Diagn Lab Immunol 11 (2004) 1140
12. Matsuzaki H., Kobayashi H., Tanakan Y., et al. Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem 278 (2003) 14640
13. Lin C.Y., Tsui K.H., Yu C.C., et al. Searching cell secreted proteomes for potential urinary bladder tumor markers. Proteomics 6 (2006) 4381
14. Greene F.L., Page D.L., Flemming I.D., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer-Verlag, New York
15. Mostofi F.K., Davis C.J., and Sesterhenn I.A. Histological typing of urinary bladder tumors. International Histological Classification of Tumors (1998), World Health Organization, Geneva
16. Shevchenko A., Wilm M., Vorm O., et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68 (1996) 850
17. Schwamborn K., Krieg R.C., Grosse J., et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol (2009) Epub ahead of print
18. Fries E., and Blom A.M. Bikunin-not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 32 (2000) 125
19. Yagyu T., Kobayashi H., Matsuzaki H., et al. Enhanced spontaneous metastasis in bikunin-deficient mice. Int J Cancer 118 (2006) 2322
20. Kobayashi H., Suzuki M., Tanaka Y., et al. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways. J Biol Chem 276 (2001) 2015
21. Andreasen P.A., Kjoller L., Christensen L., et al. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72 (1997) 1
22. Duffy M.L. Proteases as prognostic markers in cancer. Clin Cancer Res 2 (1996) 613
23. Duffy M.J., O'Grady P., Devaney D., et al. Urokinase-plasminogen activator, a marker for aggressive breast cancers. Cancer 62 (1988) 531
24. Duffy M.J., Reilly D., O'Sullivan C., et al. Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res 50 (1990) 6827
25. Oka T., Ishida T., Nishino T., et al. Immunohistochemical evidence for Urokinase plasminogen activator in primary and metastatic tumors for pulmonary carcinoma. Cancer Res 51 (1991) 3522
26. Hasui Y., Marutsuka K., Suzumiya J., et al. The content of urokinase-type plasminogen activator as a prognostic factor in bladder cancer. Int J Cancer 50 (1992) 871